PMID- 30723980
OWN - NLM
STAT- MEDLINE
DCOM- 20200130
LR  - 20200130
IS  - 1479-8301 (Electronic)
IS  - 1346-3500 (Print)
IS  - 1346-3500 (Linking)
VI  - 19
IP  - 4
DP  - 2019 Jul
TI  - A survey of doctors on diagnosis and treatment of dementia with Lewy bodies: 
      examination and treatment of behavioural and psychological symptoms.
PG  - 310-319
LID - 10.1111/psyg.12399 [doi]
AB  - BACKGROUND: Dementia with Lewy bodies (DLB) is a progressive form of dementia, 
      accompanied by a range of behavioural and psychological symptoms. The aim of this 
      study was to identify current clinical practice for the treatment of DLB in 
      Japan. METHODS: We conducted a survey of medical doctors engaged in the 
      management of dementia in Japan. Participants were divided into two groups: 
      psychiatrists (Group P) and neurologists or neurosurgeons (Group NS). Doctors 
      completed a questionnaire and we analysed their responses to compare the two 
      groups with regard to diagnosis and treatment of DLB, and in particular the 
      treatment of behavioural and psychological symptoms of dementia (BPSD). RESULTS: 
      Responses suggested that Group P conducted biomarker examinations less frequently 
      and decided on their own therapeutic strategies more frequently than did Group 
      NS. Both groups most frequently selected hallucinations/delusions as the symptoms 
      given highest treatment priority. More than 70% of respondents in both groups 
      reported having difficulties in treating BPSD. Atypical antipsychotics were more 
      frequently prescribed by Group P, but were also prescribed in 70% of patients in 
      Group NS. A third of patients received atypical antipsychotics for more than 
      1 year. CONCLUSIONS: The responses to this survey highlighted the difficulties 
      faced by clinicians managing patients with DLB and identified the need to 
      effectively treat BPSD in such patients.
CI  - (c) 2019 The Authors. Psychogeriatrics published by John Wiley & Sons Australia, 
      Ltd on behalf of Japanese Psychogeriatric Society.
FAU - Odawara, Toshinari
AU  - Odawara T
AUID- ORCID: 0000-0002-2211-782X
AD  - Health Management Center, Yokohama City University, Yokohama, Japan.
FAU - Manabe, Yuta
AU  - Manabe Y
AUID- ORCID: 0000-0002-3832-4225
AD  - Department of Dementia and Geriatric Internal Medicine, Kanagawa Dental 
      University Hospital, Yokosuka, Japan.
AD  - Department of Emergency and General Internal Medicine, Fujita Health University 
      Hospital, Toyoake, Japan.
FAU - Konishi, Osamu
AU  - Konishi O
AD  - Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd, Tokyo, Japan.
LA  - eng
GR  - Dainippon Sumitomo Pharma/
PT  - Journal Article
DEP - 20190205
PL  - England
TA  - Psychogeriatrics
JT  - Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society
JID - 101230058
RN  - 0 (Antipsychotic Agents)
SB  - IM
MH  - Adult
MH  - Antipsychotic Agents/*administration & dosage
MH  - *Delusions/diagnosis/drug therapy/etiology
MH  - Female
MH  - *Hallucinations/diagnosis/drug therapy/etiology
MH  - Humans
MH  - Japan
MH  - *Lewy Body Disease/complications/diagnosis/drug therapy
MH  - Male
MH  - Middle Aged
MH  - Neurologists/statistics & numerical data
MH  - Neurosurgeons/statistics & numerical data
MH  - Physicians/*statistics & numerical data
MH  - Psychiatry/statistics & numerical data
MH  - Surveys and Questionnaires
PMC - PMC6849712
OTO - NOTNLM
OT  - BPSD
OT  - dementia with Lewy bodies
OT  - diagnosis
OT  - survey
OT  - treatment
EDAT- 2019/02/07 06:00
MHDA- 2020/01/31 06:00
PMCR- 2019/11/12
CRDT- 2019/02/07 06:00
PHST- 2018/06/05 00:00 [received]
PHST- 2018/11/08 00:00 [revised]
PHST- 2018/12/24 00:00 [accepted]
PHST- 2019/02/07 06:00 [pubmed]
PHST- 2020/01/31 06:00 [medline]
PHST- 2019/02/07 06:00 [entrez]
PHST- 2019/11/12 00:00 [pmc-release]
AID - PSYG12399 [pii]
AID - 10.1111/psyg.12399 [doi]
PST - ppublish
SO  - Psychogeriatrics. 2019 Jul;19(4):310-319. doi: 10.1111/psyg.12399. Epub 2019 Feb 
      5.